Market Cap
$12.59 B
-$1.02 B-7.52%
7 min ago
Summary
- As of February 7, 2025, NBIX market capitalization is $12.59 billion, with a fall of -$1.02 billion (-7.52%) during the most recent trading day.
- Over the past year, NBIX market cap has dropped by -$890.18 million (-6.60%).
- NBIX market cap is now -19.54% below its all-time high of $15.65 billion.
Performance
NBIX Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Market Cap Formula
Market Cap = Price ✕ Shares Outstanding
NBIX Market Cap Trends
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
|---|---|---|---|---|
| todaytoday | -7.5% | -7.5% | +0.1% | -7.6% |
| 1 m1 month | -9.6% | -9.6% | - | -9.6% |
| 3 m3 months | -4.4% | -4.4% | - | -4.4% |
| 6 m6 months | -13.5% | -13.7% | - | -14.8% |
| ytdytd | -7.9% | -7.9% | - | -8.0% |
| 1 y1 year | -6.6% | -8.2% | +2.6% | -8.5% |
| 5 y5 years | +31.2% | +19.6% | +9.7% | +25.2% |
NBIX Market Cap Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -19.5% | $13 B | at low | |
| 3 m | 3-month | $16 B | -19.5% | $12 B | +6.2% |
| 6 m | 6-month | $16 B | -19.5% | $11 B | +12.4% |
| 1 y | 1-year | $16 B | -19.5% | $11 B | +12.4% |
| 3 y | 3-year | $16 B | -19.5% | $7.24 B | +73.8% |
| 5 y | 5-year | $16 B | -19.5% | $6.88 B | +83.2% |
| alltime | all time | $16 B | -19.5% | $73 M | >+9999.0% |
Neurocrine Biosciences Market Cap History
| Date | Value |
|---|---|
| 2025 | $12.59 B(-7.9%) |
| 2024 | $13.67 B(+4.4%) |
| 2023 | $13.10 B(+13.6%) |
| 2022 | $11.53 B(+42.6%) |
| 2021 | $8.08 B(-9.8%) |
| 2020 | $8.96 B(-9.6%) |
| 2019 | $9.92 B(+53.0%) |
| 2018 | $6.48 B(-5.9%) |
| 2017 | $6.89 B(+104.9%) |
| 2016 | $3.36 B(-31.1%) |
| 2015 | $4.88 B(+185.7%) |
| 2014 | $1.71 B(+171.6%) |
| 2013 | $629.06 M(+26.6%) |
| 2012 | $497.02 M(+5.8%) |
| 2011 | $469.73 M(+12.0%) |
| Date | Value |
|---|---|
| 2010 | $419.30 M(+250.4%) |
| 2009 | $119.66 M(-3.1%) |
| 2008 | $123.51 M(-28.9%) |
| 2007 | $173.76 M(-56.0%) |
| 2006 | $394.98 M(-83.0%) |
| 2005 | $2.33 B(+29.3%) |
| 2004 | $1.80 B(-6.5%) |
| 2003 | $1.93 B(+37.6%) |
| 2002 | $1.40 B(-10.1%) |
| 2001 | $1.56 B(+85.7%) |
| 2000 | $838.54 M(+56.8%) |
| 1999 | $534.80 M(+310.9%) |
| 1998 | $130.15 M(-6.6%) |
| 1997 | $139.29 M(-24.2%) |
| 1996 | $183.70 M |
FAQ
- What is Neurocrine Biosciences market capitalization?
- What is the all time high market cap for Neurocrine Biosciences?
- What is NBIX market capitalization year-to-date change?
- What is Neurocrine Biosciences market cap year-on-year change?
What is Neurocrine Biosciences market capitalization?
The current market cap of NBIX is $12.59 B
What is the all time high market cap for Neurocrine Biosciences?
Neurocrine Biosciences all-time high market capitalization is $15.65 B
What is NBIX market capitalization year-to-date change?
Neurocrine Biosciences market capitalization has changed by -$1.08 B (-7.89%) since the beginning of the year
What is Neurocrine Biosciences market cap year-on-year change?
Over the past year, NBIX market capitalization has changed by -$890.18 M (-6.60%)